Back to top
more

Macquarie Healthcare Fund A: (MF: DLHAX)

(NASDAQ Mutual Funds) As of Apr 15, 2026 05:41 PM ET

$25.94 USD

-0.07 (-0.27%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

3-Hold of 5     3    

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Mar 31, 2026

Total Return %* Percentile Rank Objective
YTD -2.99 21
3 months -2.99 21
6 months 9.27 47
1 Year 17.39 31
3 Year 11.54 20
5 Year 7.05 18
10 Year 10.54 23

* Annual for three years and beyond.

Zacks Premium Research for DLHAX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Hold 3
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 32.41
% Yield 2.39
% SEC Yield NA
Net Assets (Mil $) 3/31/2026 168.83
% Turnover 3/31/2026 5.00

Risk

3 Year 5 Year 10 Year
Beta 0.57 0.55 0.69
Alpha -0.20 -0.71 0.44
R Squared 0.26 0.37 0.49
Std. Dev. 13.48 13.68 14.93
Sharpe 0.56 0.33 3.00

Sector / Country Weightings

As of 3/31/2026 % of Portfolio
Health 56.64
Other 15.84
Finance 13.50
Services 10.75
Technology 1.70
Retail Trade 0.86
Industrial Cyclical 0.71

Portfolio Holdings

Top Equity Holdings
(As of 12/31/2025)
% of Portfolio Value (Mil$)
REGENERON PHARMACEUTICALS 5.23 36.28
UCB SA 5.23 36.26
ELI LILLY & CO 4.34 30.09
ABBVIE INC 4.12 28.56
PFIZER INC 4.11 28.51
MERCK & CO INC 4.10 28.42
GILEAD SCIENCES INC 3.72 25.78
ASTRAZENECA PLC 3.50 24.29
BOSTON SCIENTIFIC CORP 3.44 23.84

Stock Holding % of Net Assets

As Of 12/31/2025
Total Issues 102
Avg. P/E 28.16
Avg. P/Book 6.07
Avg. EPS Growth 16
Avg. Market Value (Mil $) 149,400

Composition

% of Portfolio
Stocks 99.68
Foreign Stocks 15.77
Cash 0.10
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.00
Other 0.22
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 4.28
Small Growth 5.17
Small Value 0.99
Foreign Stock 12.39
Emerging Market 0.00
Precious Metal 0.85
Intermediate Bond 33.10
Foreign Bond 0.00
High Yield Bond 0.00